Optimal serial dilutions designs for drug discovery experiments

Journal of Biopharmaceutical Statistics

Volumn 21, Issue 3, 2011, Pages 484-497

  Donev, Alexander N ^a   Tobias, Randall D ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SAS INSTITUTE INC   (United States)

Author keywords

Bioassay; Dose response study; High throughput screening; Minimum significant difference; Population D and DS optimality

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DILUTION; DOSE RESPONSE; DRUG DETERMINATION; DRUG DEVELOPMENT; DRUG POTENCY; EXPERIMENTAL DESIGN; IC 50; MAXIMUM PERMISSIBLE DOSE; PRIORITY JOURNAL;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DISCOVERY; MODELS, BIOLOGICAL; RESEARCH DESIGN;

EID: 79953224121     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543406.2010.481801     Document Type: Article

References (15)

1. Atkinson, A. C., Donev, A. N., Tobias, R. D. (2007). Optimum Experimental Designs, With SAS. Oxford: Clarendon Press
2. Bates, D. M., Watts, D. G. (2007). Nonlinear Regression Analysis and Its Applications. New York: Wiley
3. Bhat, J., Rane. R., Solapure, S., Surkar, D., Sharma, U., Harish, M. N., Lamb, S., Plant D., Alcock, P., Peters, S., Barde, S., Roy, R. K. (2006). High-throughput screening of RNA polymerase inhibitors using a fluorescent UTP analog. Journal of BiomolecularScreening 11:968-976 (Pubitemid 44847151)
4. Donev, A. N., Tobias, R. D., Monadjemi, F. (2008). Cost-cautious designs for confirmatory bioassay. Journal of Statistical Planning and Inference 138:3805-3812
5. Eastwood, B. J., Farmen, M. W., Iversen, P. W., Craft, T. J., Smallwood, J. K., Garbison, K. E., Delapp, N. W., Smith, G. F. (2006). The minimum significant ratio: a statistical parameter to characterize the reproducibility of potency estimates from concentrationresponse assays and estimation by replicate-experiment studies. Journal of Biological Screening 11:253-261
6. Finney, D. J. (1978). Statistical Methods in Biological Assay. 3rd ed. London: Charles Griffin & Co., pp. 69-147
7. Fox, S., Farr-Jones, S. Sopchak, L., Boggs, A., Nicely, H., Khoury, R., Biros, M. (2006). High-throughput screening: Update on practices and success. Journal of Biomolecular Screening 11:864-869. (Pubitemid 44562328)
8. Hill, A. V. (1913). The combinations of haemoglobin with oxygen and with carbon monoxide. Biochem. J. 7:471-480.
9. Lee, M.-L. T., Whitmore, G. A. (1999). Statistical inference for serial dilution assay data. Biometrics 55:1215-1220
10. Macken, C. (1999). Design and analysis of serial limiting dilution assays with small sample sizes. Journal of Immunological Methods 222:13-29 (Pubitemid 29023699)
11. Mehrabi, Y., Matthews, J. N. S. (1998). Implementable Bayesian designs for limiting dilution assays. Biometrics 54:1398-1406 (Pubitemid 29018623)
12. Parker, G. J., Law, T. L., Lenoch, F. J., Bolger, R. E. (2000). Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand binding and kinase/phosphatase assays. Journal of Biomolecular Screening 5:77-88 (Pubitemid 30243877)
13. Ritz, C., Streibig, J. C. (2005). Bioassay analysis using R. Journal of Statistical Software 12(5):1-22 (Pubitemid 40218001)
14. Seber, G. A. F., Wild, C. J. (2005). Nonlinear Regression. New York: Wiley
15. Strijbosch, L. W. G., Does, R. J. M. M., Buurman, W. A. (1988). Computer aided design and evaluation of limiting and serial dilution experiments. International Journal of Bio-Medical Computing 23:279-290